2011
DOI: 10.1208/s12249-011-9637-7
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of Structural Variability in Pharmaceutical Excipients Using Solid-State NMR Spectroscopy

Abstract: Abstract. Polysaccharide-based excipients comprise the majority of most solid dosage forms and can vary dramatically in terms of structural and functionally related properties. Analytical methods for characterizing these important formulation components are crucial. Solid-state NMR spectroscopy (SSNMR) can provide a wealth of information on these materials while offering the advantages of nondestructive sample preparation and selectivity. The overall objective of this work is to identify SSNMR parameters that … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 25 publications
0
10
0
1
Order By: Relevance
“…110-135 ppm), e CP ( 13 C) = 32, is less than that of the solvent. Finally, there are features that correspond to various types of excipient molecules, including polysaccharides (20-40 ppm), synthetic polymers (60-75 ppm) and stearates (100-110 ppm), 69,97,98 which have enhancements ranging from 12 to 50. Overlapping signals from the API and excipient make it challenging to determine the phase of an API in 13 C NMR spectra even without the use of DNP; 21 however, the differences in the DNP-enhancement such as those observed in the spectra of isox can further complicate the analysis.…”
Section: Isoxsuprine Hclmentioning
confidence: 99%
“…110-135 ppm), e CP ( 13 C) = 32, is less than that of the solvent. Finally, there are features that correspond to various types of excipient molecules, including polysaccharides (20-40 ppm), synthetic polymers (60-75 ppm) and stearates (100-110 ppm), 69,97,98 which have enhancements ranging from 12 to 50. Overlapping signals from the API and excipient make it challenging to determine the phase of an API in 13 C NMR spectra even without the use of DNP; 21 however, the differences in the DNP-enhancement such as those observed in the spectra of isox can further complicate the analysis.…”
Section: Isoxsuprine Hclmentioning
confidence: 99%
“…[25][26][27] Solid-state nuclear magnetic resonance (NMR) has been demonstrated as one of the most informative analytic technique used in the field of pharmaceutical sciences. [28,29] NMR allows the structural characterisation of drugs [30] and excipients, [31] identification of drug polymorphs, [32] understanding of molecular mobility and physical stability of solid dispersions, [33] and the study and identification of specific intramolecular interactions in the solid dispersion. [34] The knowledge of the accurate assignments of the NMR signals in the HPMC-AS polymer used for ASDs plays a crucial role in understanding HPMC-AS-API interactions and is required to study the overall stability and dynamics of the ASD.…”
Section: Introductionmentioning
confidence: 99%
“…source-to-source variability) (12,14). To se posebno odnosi na ekscipijense mineralnog, biljnog, životinjskog i mikrobiološkog porekla, čije karakteristike mogu značajno da variraju, zavisno od porekla i/ili sezone prikupljanja sirovina (15,16). Iz ovih razloga, proizvodnja ekscipijenasa obično uključuje niz postupaka koji imaju za cilj da se eliminiše varijabilnost izazvana razlikama u polaznim sirovinama.…”
Section: Varijabilnost (Promenljivost Karakteristika) Ekscipijenasaunclassified